MetaADEDB 2.0 @ LMMD
Full blood count abnormal
(UMLS:C0438216)
UMLS ID:
C0438216
MeSH ID:
N/A
Synonym(s)
1.
Full blood count abnormal
2.
Complete blood count abnormal
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1LenalidomideFAERS: 64US FAERS
2ClozapineFAERS: 56
Canada Vigilance: 4
Canada Vigilance
US FAERS
3palbociclibFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
4Imatinib MesylateFAERS: 16US FAERS
5pomalidomideFAERS: 14US FAERS
6Ruxolitinib phosphateFAERS: 13US FAERS
74-AminopyridineFAERS: 12US FAERS
8Fingolimod HydrochlorideFAERS: 10US FAERS
9Zoledronic AcidFAERS: 7US FAERS
10CapecitabineFAERS: 6US FAERS
11Dimethyl FumarateFAERS: 6US FAERS
124-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 5US FAERS
13IsotretinoinFAERS: 5US FAERS
14RivaroxabanFAERS: 5US FAERS
15niraparibFAERS: 5US FAERS
16tofacitinibFAERS: 5US FAERS
17LevofloxacinFAERS: 4US FAERS
18PCI 32765FAERS: 4US FAERS
19SunitinibFAERS: 4US FAERS
20ThalidomideFAERS: 4US FAERS
21AlendronateFAERS: 3US FAERS
22AtorvastatinFAERS: 3US FAERS
23FenofibrateFAERS: 3US FAERS
24LevetiracetamFAERS: 3US FAERS
25MDV 3100FAERS: 3US FAERS
26OctreotideFAERS: 3US FAERS
27PregabalinFAERS: 3US FAERS
28venetoclaxFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
295-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amineFAERS: 2US FAERS
30BortezomibFAERS: 2US FAERS
31Cabozantinib S-malateFAERS: 2US FAERS
32DabigatranFAERS: 2US FAERS
33EverolimusFAERS: 2US FAERS
34MethotrexateFAERS: 2US FAERS
35OlanzapineFAERS: 2US FAERS
36TacrolimusFAERS: 2US FAERS
37WarfarinFAERS: 2US FAERS
38ambrisentanFAERS: 2US FAERS
39carfilzomibFAERS: 2US FAERS
40etonogestrelFAERS: 2US FAERS
41midostaurinFAERS: 2US FAERS
42olaparibFAERS: 2US FAERS
43ponatinibFAERS: 2US FAERS
442-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triolFAERS: 1US FAERS
45BaclofenFAERS: 1US FAERS
46Bendamustine HydrochlorideFAERS: 1US FAERS
47CrizotinibFAERS: 1US FAERS
48CyclophosphamideFAERS: 1US FAERS
49CyclosporineFAERS: 1US FAERS
50DaptomycinFAERS: 1US FAERS
51DasatinibFAERS: 1US FAERS
52DeferasiroxFAERS: 1US FAERS
53DiclofenacFAERS: 1US FAERS
54DocetaxelFAERS: 1US FAERS
55Docusate sodiumFAERS: 1US FAERS
56EpoprostenolFAERS: 1US FAERS
57FinasterideFAERS: 1US FAERS
58Imatinib MesylateFAERS: 1US FAERS
59LamotrigineFAERS: 1US FAERS
60LinezolidFAERS: 1US FAERS
61Medroxyprogesterone AcetateFAERS: 1US FAERS
62MefloquineFAERS: 1US FAERS
63MesalamineFAERS: 1US FAERS
64MetforminFAERS: 1US FAERS
65MethotrexateFAERS: 1US FAERS
66MoxifloxacinFAERS: 1US FAERS
67NaltrexoneFAERS: 1US FAERS
68NitrofurantoinFAERS: 1US FAERS
69NorgestrelFAERS: 1US FAERS
70OrlistatFAERS: 1US FAERS
71PhentermineFAERS: 1US FAERS
72PrednisoneFAERS: 1US FAERS
73Quetiapine FumarateFAERS: 1US FAERS
74Rosuvastatin CalciumFAERS: 1US FAERS
75SertralineFAERS: 1US FAERS
76SimeprevirFAERS: 1US FAERS
77SorafenibFAERS: 1US FAERS
78TadalafilFAERS: 1US FAERS
79TemozolomideFAERS: 1US FAERS
80TeriparatideFAERS: 1US FAERS
81TestosteroneFAERS: 1US FAERS
82Valproic AcidFAERS: 1US FAERS
83Valproic AcidFAERS: 1US FAERS
84Viekira PakFAERS: 1US FAERS
85WarfarinFAERS: 1US FAERS
86apixabanFAERS: 1US FAERS
87apremilastFAERS: 1US FAERS
88benazeprilFAERS: 1US FAERS
89bosutinibFAERS: 1US FAERS
90elbasvir-grazoprevir drug combinationFAERS: 1US FAERS
91eltrombopagFAERS: 1US FAERS
92fexofenadineFAERS: 1US FAERS
93oxybutyninFAERS: 1US FAERS
94reviparinFAERS: 1US FAERS
95rofecoxibFAERS: 1US FAERS
96rucaparibFAERS: 1US FAERS
97MirtazapineCanada Vigilance: 1Canada Vigilance
98OctreotideCanada Vigilance: 1Canada Vigilance
99teriflunomideCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.